-
-
-
-
-
-
-
Dr. Reddy’s Q2 FY24 Financial Results
-
-
-
-
-
-
-
Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany
-
-
-
-
-
-
-
Citius Pharmaceuticals Acquires Dr. Reddy's Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications
-
-
-
-
-
-
-
Dr. Reddy’s Q1 FY21 Financial Results
-
-
-
-
-
-
-
Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®
-
-
-
-
-
-
-
Dr. Reddy’s Laboratories Breathes New Life into Doan’s® in New Marketing Campaign
-
-
-
-
-
-
1,160,615 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

